Transporters as a determinant of drug clearance and tissue distribution
- PMID: 16488580
- DOI: 10.1016/j.ejps.2005.12.003
Transporters as a determinant of drug clearance and tissue distribution
Abstract
Transporters play an important role in the processes of drug absorption, distribution and excretion. In this review, we have focused on the involvement of transporters in drug excretion in the liver and kidney. The rate of transporter-mediated uptake and efflux determines the rate of renal and hepatobiliary elimination. Transporters are thus important as a determinant of the clearance in the body. Even when drugs ultimately undergo metabolism, their elimination rate is sometimes determined by the uptake rate mediated by transporters. Transporters regulate the pharmacological and/or toxicological effect of drugs because they limit their distribution to tissues responsible for their effect and/or toxicity. For example, the liver-specific distribution of some statins via organic anion transporters helps them to produce their high pharmacological effect. On the other hand, as in the case of metformin taken up by organic cation transporter 1, drug distribution to the tissue(s) may enhance its toxicity. As transporter-mediated uptake is a determinant of the drug elimination rate, drug-drug interactions involving the process of transporter-mediated uptake can occur. In this review, we have introduced some examples and described their mechanisms. More recently, some methods to analyze such transporter-mediated transport have been reported. The estimation of the contributions of transporters to the net clearance of a drug makes it possible to predict the net clearance from data involving drug transport in transporter-expressing cells. Double transfected cells, where both uptake and efflux transporters are expressed on the same polarized cells, are also helpful for the analysis of the rate of transporter-mediated transcellular transport.
Similar articles
-
The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.Can J Clin Pharmacol. 2003 Spring;10(1):17-23. Can J Clin Pharmacol. 2003. PMID: 12687033 Review.
-
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance.Xenobiotica. 2012 Jan;42(1):28-45. doi: 10.3109/00498254.2011.626464. Epub 2011 Nov 11. Xenobiotica. 2012. PMID: 22077101 Review.
-
The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.Eur J Pharm Sci. 2013 Jul 16;49(4):767-72. doi: 10.1016/j.ejps.2013.04.030. Epub 2013 May 3. Eur J Pharm Sci. 2013. PMID: 23648783
-
Disposition of metformin: variability due to polymorphisms of organic cation transporters.Ann Med. 2012 Mar;44(2):119-29. doi: 10.3109/07853890.2010.549144. Epub 2011 Mar 3. Ann Med. 2012. PMID: 21366511 Review.
-
[Role of transporters in hepatic drug disposition].Yao Xue Xue Bao. 2012 May;47(5):565-72. Yao Xue Xue Bao. 2012. PMID: 22811997 Review. Chinese.
Cited by
-
Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide.Pharm Res. 2013 Apr;30(4):1188-99. doi: 10.1007/s11095-012-0956-5. Epub 2013 Jan 10. Pharm Res. 2013. PMID: 23307347
-
Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model.Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):395-402. doi: 10.1007/s13318-015-0271-8. Epub 2015 Mar 10. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25753830
-
Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes.Eur J Drug Metab Pharmacokinet. 2019 Feb;44(1):13-30. doi: 10.1007/s13318-018-0502-x. Eur J Drug Metab Pharmacokinet. 2019. PMID: 30167999 Review.
-
Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver.World J Clin Cases. 2019 Dec 6;7(23):3915-3933. doi: 10.12998/wjcc.v7.i23.3915. World J Clin Cases. 2019. PMID: 31832394 Free PMC article. Review.
-
Why 90% of clinical drug development fails and how to improve it?Acta Pharm Sin B. 2022 Jul;12(7):3049-3062. doi: 10.1016/j.apsb.2022.02.002. Epub 2022 Feb 11. Acta Pharm Sin B. 2022. PMID: 35865092 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials